Patent Assignment
Reel/Frame 018866/0549
Release of Security Interest
Recorded: 2007-02-08
Received: 2007-02-08
Pages: 6
Assignor
DENT, AS COLLATERAL AGENT, DAVID
Executed: 2006-07-25
Assignee
HUMANETICS CORPORATION
10400 VIKING DRIVE, SUITE 100, EDEN PRAIRIE, MN, 55344, UNITED STATES
Covered Properties
(10)
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Syndrome
Application:
10/433,043 →
Use of DELTA5-Androstene-3BETA-Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Application:
10/431,960 →
Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal
Application:
10/340,980 →
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application:
60/439,753 →
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application:
60/439,816 →
Combination of Pinitol and Creatine to Enhance Uptake and Retention of Creatine
Application:
10/240,611 →
Treatment of Menorrhagia, Hypermenorrhea, Dysmenorrhea and Menstrual Migraines by the Administration of an Antibacterial Milk Product
Application:
09/683,070 →
Stimulating Transport of Glucose into Animal Tissue by the Administration of Pinitol
Application:
09/857,245 →
Treatment of Dermatitis by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Application:
09/805,024 →
Method for Diminishing Wrinkles and Fine Lines of the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7, 17 Dione and Metabolizable Precursors Thereof
Application:
09/799,295 →